Claims for Patent: 8,709,491

Summary for Patent: 8,709,491

Title:	Composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particles
Abstract:	The invention relates to dosage forms that provide prolonged therapy. In particular, the invention relates to dosage forms including various pluralities of drug-containing resin particles. In a particular embodiment, the drug dosage form comprises a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particles. The invention also relates to methods of making these dosage forms and methods of treating using these dosage forms.
Inventor(s):	Tengler; Mark (Colleyville, TX), McMahen; Russell (Flower Mound, TX)
Assignee:	NEOS Terapeutics, LP (Grand Prairie, TX)
Application Number:	13/947,881
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,709,491
Patent Claims:	1. A pharmaceutical composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particles, wherein said composition comprises 20 to 50% of a first plurality of drug-resin particles that are uncoated and 50 to 80% of a second plurality of drug-resin particles that are coated with a delayed release coating. 2. The composition of claim 1, wherein the second plurality of drug resin particles comprises a triggered-release coating triggered by a pH change. 3. The composition of claim 2, wherein the triggered-release coating is cellulose acetate phthalate, cellulose acetate trimellitate, hydroxypropyl methylcellulose phthalate, polyvinyl acetate phthalate, carboxymethylethylcellulose, co-polymerized methacrylic acid/methacrylic acid methyl esters, co-polymerized methacrylic acid/acrylic acid ethyl esters, or mixtures thereof. 4. The composition of claim 1, wherein the resin particles are strong acidic cation exchange resins, selected from the group consisting of polistirex, polacrilex, cholestyramine, polacrilin or mixtures thereof. 5. The composition of claim 1, wherein the composition comprises 40%-50% of the first plurality of drug-resin particles and 50-60% of the second plurality of drug-resin particles. 6. The composition of claim 5, wherein the composition comprises about 45% of the first plurality of drug-resin particles and about 55% of the second plurality of drug-resin particles. 7. The composition of claim 1, wherein the composition is a liquid suspension, chewable composition, or an orally disintegrating tablet composition. 8. The composition of claim 1, wherein said drug-resin particles comprise 25% levo-amphetamine and 75% dextro-amphetamine. 9. The composition of claim 1, wherein the amount of ADHD effective agent is 2-60 mg.